astrazeneca glp-1 Oral Small-Molecule Receptor Agonists: Mechanistic Insights and Emerging Therapeutic Strategies eccogene glp 1 AstraZeneca Presents

Poor short-term glycemic control in patients with type 2 diabetes impairs the intestinal mucosal barrier: A prospective, single-center, observational study

: "Hepatoprotective effects of a self-micro emulsifying drug delivery system containing Silybum marianum native seed oil against experimentally induced liver injury." in: Die Pharmazie , Vol

Gemigliptin: Gemigliptin is a medication used for the management of type 2 diabetes mellitus

I find that it read more You'll also get the latest articles directly to your inbox

Key Findings from Studies on Animals Mouse Studies: Dopamine Release: In one study, mice were given a small dose of a GLP-1 receptor agonist called liraglutide

elegans CED-4, participates in cytochrome c-dependent activation of caspase-3